Initiation of antiretroviral therapy during primary HIV-1 infection may well redefine the course of the disease by controlling the burst of viral replication and subsequent immune dysfunction. At present, treatment of acute primary HIV-1 should remain largely in the domain of clinical investigation. There are significant problems in providing constant vigilance to medication and subsequent viral suppression. Only clinical trials can define the relative benefit of initiating antiretrovirals during this stage of infection.
CITATION STYLE
Corey, L., & Berrey, M. M. (1999). Antiretroviral therapy in primary HIV. In Advances in Experimental Medicine and Biology (Vol. 458, pp. 223–227). Kluwer Academic/Plenum Publishers. https://doi.org/10.1007/978-1-4615-4743-3_21
Mendeley helps you to discover research relevant for your work.